Apolipoprotein E ε4 allele and Japanese late-onset depressive disorders

Biological Psychiatry

Volumn 45, Issue 3, 1999, Pages 308-312

  Ohara, Koichi ^a   Nagai, Miho ^a   Suzuki, Yasuo ^b   Yoshida, Katsuaki ^c   Tsukamoto, Toshio ^a   Ohara, Kenshiro ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Gessho An Clinic   (Japan)

^c Yokohama Aihara Hospital   (Japan)

Author keywords

4 allele; Apolipoprotein E; Dementia; Depression; Late onset; Polymorphism

Indexed keywords

APOLIPOPROTEIN E4; APOLIPOPROTEIN E;

ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DEMENTIA; DEPRESSION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; AGED; ANALYSIS OF VARIANCE; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CLASSIFICATION; ETHNOLOGY; GENETICS; MIDDLE AGED; POLYMERASE CHAIN REACTION; SURVIVAL;

ADULT; AGE OF ONSET; AGED; ALLELES; ANALYSIS OF VARIANCE; APOLIPOPROTEINS E; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; DEMENTIA; DEPRESSIVE DISORDER; FEMALE; GENOTYPE; HUMANS; JAPAN; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; SURVIVAL ANALYSIS;

EID: 0033068158     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(97)00548-9     Document Type: Article

References (47)

1. Alexopoulos G.S., Meyers B.S., Young R.C., Mattis S., Kakuma T. The course of geriatric depression with "reversible dementia" A controlled study . Am J Psychiatry. 150:1993;1693-1699.
2. Amouyel P., Vidal O., Launay J.M., Laplanche J.L. The apolipoprotein E alleles as major susceptibility factors for Creutzfeldt-Jakob disease. The French Research Group on Epidemiology of Human Spongiform Encephalopathies. Lancet. 344:1994;1315-1318.
3. Baron M., Mendlewicz J., Klotz J. Age-of-onset and genetic transmission in affective disorders. Acta Psychiatr Scand. 64:1981;373-380.
4. Bergem A.L., Engedal K., Kringlen E. The role of heredity in late-onset Alzheimer disease and vascular dementia. A twin study. Arch Gen Psychiatry. 54:1997;264-270.
5. Corder E.H., Saunders A.M., Strittmatter W.J., et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 261:1993;921-923.
6. Couderc R., Mahieux F., Bailleul S., et al. Prevalence of apolipoprotein E phenotypes in ischemic cerebrovascular disease A case-control study . Stroke. 24:1993;661-664.
7. Davignon J., Gregg R.E., Sing C.F. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis. 8:1988;1-21.
8. Endicott J., Spitzer R.L. A diagnostic interview The Schedule for Affective Disorders and Schizophrenia . Arch Gen Psychiatry. 35:1978;837-844. [translated into Japanese by Hosaki H, Kitamura T, Kato M, Sakio E, Shima S, and Takahashi R; Tokyo: Seiwa Shoten Publishers, 1983].
9. Engelberg H. Low serum cholesterol and suicide. Lancet. 339:1992;727-729.
10. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-Mental State" A practical method for grading the cognitive state of patients for the clinician . J Psychiatr Res. 12:1975;189-198.
11. Frisoni G.B., Calabresi L., Geroldi C., et al. Apolipoprotein E ε4 allele in Alzheimer's disease and vascular dementia. Dementia. 5:1994;240-242.
12. Fujikawa T., Yamawaki S., Touhouda Y. Incidence of silent cerebral infarction in patients with major depression. Stroke. 24:1993;1631-1634.
13. Hallman D.M., Boerwinkle E., Saha N., et al. The apolipoprotein E polymorphism A comparison of allele frequencies and effects in nine populations . Am J Hum Genet. 49:1991;338-349.
14. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-62.
15. Harrington C.R., Louwagie J., Rossau R., et al. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Am J Pathol. 145:1994;1472-1484.
16. Heidrich A., Thome J., Rösler M., Baumer A. Apolipoprotein E-ε 4 allele frequency in late-onset depression. Biol Psychiatry. 41:1997;912.
17. Igata-Yi R., Igata T., Ishizuka K., et al. Apolipoprotein E genotype and psychosis. Biol Psychiatry. 41:1997;906-908.
18. Kawamata J., Tanaka S., Shimohama S., Ueda K., Kimura J. Apolipoprotein E polymorphism in Japanese patients with Alzheimer's disease or vascular dementia. J Neurol Neurosurg Psychiatry. 57:1994;1414-1416.
19. Kosunen O., Talasniemi S., Lehtovirta M., et al. Relation of coronary atherosclerosis and apolipoprotein E genotypes in Alzheimer patients. Stroke. 26:1995;743-748.
20. Krishnan K.R.R., Tupler L.A. Apolipoprotein E-ε 4 allele frequency in late-onset depression [response]. Biol Psychiatry. 41:1997;912-913.
21. Krishnan K.R.R., Goli V., Ellinwood E.H., et al. Leukoencephalopathy in patients diagnosed as major depressive. Biol Psychiatry. 23:1988;519-522.
22. Krishnan K.R.R., Hays J.C., Tupler L.A., George L.K., Blazer D.G. Clinical and phenomenological comparisons of late-onset and early-onset depression. Am J Psychiatry. 152:1995;785-788.
23. Krishnan K.R.R., Tupler L.A., Ritchie J.C. Jr, et al. Apolipoprotein E-ε 4 frequency in geriatric depression. Biol Psychiatry. 40:1996;69-71.
24. Krishnan K.R.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. Am J Psychiatry. 154:1997;497-501.
25. Lesser I.M., Miller B.L., Boone K.B. Brain imaging and cognitive function in late-onset psychotic depression. J Neuropsychiatry. 3:1991;33-40.
26. Morgan R.E., Palinkas L.A., Barrett-Connor E., Wingard D.L. Plasma cholesterol and depressive symptoms in older men. Lancet. 341:1993;75-79.
27. Murphy G.M. Jr, Taylor J., Kraemer H.C., Yesavage J., Tinklenberg J.R. No association between apolipoprotein E ε 4 allele and rate of decline in Alzehimer's disease. Am J Psychiatry. 154:1997;603-608.
28. Nakagawa Y., Kitamoto T., Furukawa H., Ogomori K., Tateishi J. Allelic variation of apolipoprotein E in Japanese sporadic Creutzfeldt-Jakob disease patients. Neurosci Lett. 187:1995;209-211.
29. Noguchi S., Murakami K., Yamada N. Apolipoprotein E genotype and Alzheimer's disease. Lancet. 342:1993;737.
30. Payami H., Grimslid H., Oken B., et al. A prospective study of cognitive health in the elderly (Oregon brain aging study) Effects of family history and apolipoprotein E genotype . Am J Hum Genet. 60:1997;948-956.
31. Pedro-Botet J., Senti M., Nogues X., et al. Lipoprotein and apolipoprotein profile in men with ischemic stroke Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism . Stroke. 23:1992;1557-1562.
32. Ramachandran G., Marder K., Tang M., et al. A preliminary study of apolipoprotein E genotype and psychiatric manifestations of Alzheimer's disease. Neurology. 47:1996;256-259.
33. Salvatore M., Seeber A.C., Nacmias B., Petraroli R., D'Alessandro M., Sorbi S., et al. Apolipoprotein E in sporadic and familial Creutzfeldt-Jakob disease. Neurosci Lett. 199:1995;95-98.
34. Saunders A.M., Roses A.D. Apolipoprotein E4 allele frequency, ischemic cerebrovascular disease, and Alzheimer's disease [letter]. Stroke. 24:1993;1416.
35. Saunders A.M., Strittmatter W.J., Schmechel D., et al. Association of apolipoprotein E allele ε 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 43:1993;1467-1472.
36. Strittmatter W.J., Saunders A.M., Schmechel D., et al. Apolipoprotein E High-avidity binding to β-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer's disease . Proc Natl Acad Sci USA. 90:1993;1977-1981.
37. Sulkava R., Kainulainen K., Verkkoniemi A., et al. APOE alleles in Alzheimer's disease and vascular dementia in a population aged 85+. Neurobiol Aging. 17:1996;373-376.
38. Utermann G.U., Langenback U., Beisiegel U., Weber W. Genetics of the apolipoprotein E system in man. Am J Hum Genet. 32:1980;339-347.
39. Wang L., Hirayasu K., Ishizawa M., Kobayashi Y. Purification of genomic DNA from human whole blood by isopropanol-fractionation with concentrated NaI and SDS. Nucleic Acids Res. 22:1994;1774-1775.
40. Wenham P.R., Price W.H., Blundell G. Apolipoprotein E genotyping by one-stage PCR. Lancet. 337:1991;1158-1159.
41. World Health Organization (1993): The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic Criteria for Research. Geneva: World Health Organization [translated into Japanese by Nakane Y, Okazaki Y, Fujiwara T; Tokyo: Igaku-Shoin, 1994].
42. Wragg R., Jeste D. Overview of depression and psychosis in Alzheimer's disease. Am J Psychiatry. 146:1989;577-587.
43. Yoshizawa T., Yamakawa-Kobayashi K., Komatsuzaki Y., et al. Dose-dependent association of apolipoprotein E allele ε 4 with late-onset, sporadic Alzheimer's disease. Ann Neurol. 36:1994;656-659.
44. Zannis V.I., Breslow J.L. Human VLDL apo E isoprotein polymorphism is explained by genetic variation and post-translational modification. Biochemistry. 20:1981;1033-1041.
45. Zerr I., Helmhold M., Poser S., Armstrong V.W., Weber T. Apolipoprotein E phenotype frequency and cerebrospinal fluid concentration are not associated with Creutzfeldt-Jakob disease. Arch Neurol. 53:1996;1233-1238.
46. Zubenko G.S., Stiffler S., Stabler S., et al. Association of the apolipoprotein E ε 4 allele with clinical subtypes of autopsy-confirmed Alzheimer's disease. Am J Med Genet. 54:1994;199-205.
47. Zubenko G.S., Henderson R., Stiffler J.S., et al. Association of the APOE ε 4 allele with clinical subtypes of late life depression. Biol Psychiatry. 40:1996;1008-1016.